Results: 25
Cover Image, Volume 83, Issue 3.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. i, doi. 10.1002/ddr.21955
- By:
- Publication type:
- Article
An overview of sulfonamide‐based conjugates: Recent advances for tuberculosis treatment.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 567, doi. 10.1002/ddr.21913
- By:
- Publication type:
- Article
Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic mice.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 735, doi. 10.1002/ddr.21905
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of N‐[1‐(6′‐chloropyridazin‐3′‐yl)‐3‐(4″‐substitutedphenyl)‐1H‐pyrazole‐5‐yl]alkanamides as anti‐inflammatory agents
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 811, doi. 10.1002/ddr.21912
- By:
- Publication type:
- Article
Discovery of substituted indole derivatives as allosteric inhibitors of m<sup>6</sup>A‐RNA methyltransferase, METTL3‐14 complex.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 783, doi. 10.1002/ddr.21910
- By:
- Publication type:
- Article
Synthesis and evaluation of 2‐aryl‐1H‐benzo[d]imidazole derivatives as potential microtubule targeting agents.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 769, doi. 10.1002/ddr.21909
- By:
- Publication type:
- Article
CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR‐153‐3p/ATF2 axis and wnt/β‐catenin pathway.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 755, doi. 10.1002/ddr.21908
- By:
- Publication type:
- Article
Synthesis of novel hybrid pharmacophore of N‐((4‐sulfamoylphenyl)carbamothioyl)alkanamides as potent carbonic anhydrase‐II and 15‐lipoxygenase inhibitors.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 745, doi. 10.1002/ddr.21906
- By:
- Publication type:
- Article
Mitoquinone intravitreal injection ameliorates retinal ischemia–reperfusion injury in rats involving SIRT1/Notch1/NADPH axis.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 800, doi. 10.1002/ddr.21911
- By:
- Publication type:
- Article
Sinapic acid inhibits pancreatic cancer proliferation, migration, and invasion via downregulation of the AKT/Gsk‐3β signal pathway.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 721, doi. 10.1002/ddr.21904
- By:
- Publication type:
- Article
Platycodin D inhibits the malignant progression of papillary thyroid carcinoma by NF‐κB and enhances the therapeutic efficacy of pembrolizumab.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 708, doi. 10.1002/ddr.21902
- By:
- Publication type:
- Article
Terbutaline attenuates LPS‐induced injury of pulmonary microvascular endothelial cells by cAMP/Epac signaling.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 699, doi. 10.1002/ddr.21901
- By:
- Publication type:
- Article
Antiproliferative, antimigratory, and prooxidative potential of novel platinum(IV) complexes and resveratrol on breast cancer (MDA‐MB‐231) and choriocarcinoma (JEG‐3) cell lines.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 688, doi. 10.1002/ddr.21900
- By:
- Publication type:
- Article
Oleanolic acid reduces oxidative stress and neuronal apoptosis after experimental subarachnoid hemorrhage by regulating Nrf2/HO‐1 pathway.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 680, doi. 10.1002/ddr.21899
- By:
- Publication type:
- Article
Sodium tanshinone IIA sulfonate promotes spinal cord injury repair by inhibiting blood spinal cord barrier disruption in vitro and in vivo.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 669, doi. 10.1002/ddr.21898
- By:
- Publication type:
- Article
Parecoxib ameliorates renal toxicity and injury in sepsis‐induced mouse model and LPS‐induced HK‐2 cells.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 659, doi. 10.1002/ddr.21897
- By:
- Publication type:
- Article
A comparative study of the in vitro antitumor effect of mannose‐doxorubicin conjugates with different linkers.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 646, doi. 10.1002/ddr.21896
- By:
- Publication type:
- Article
Structure and activity of an anti‐epidermal growth factor receptor antibody without galactose‐α‐1,3‐galactose residues.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 637, doi. 10.1002/ddr.21894
- By:
- Publication type:
- Article
Discovery and structure–activity relationships of the quinolinequinones: Promising antimicrobial agents and mode of action evaluation.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 628, doi. 10.1002/ddr.21893
- By:
- Publication type:
- Article
d‐Galactose treatment increases ACE2, TMPRSS2, and FURIN and reduces SERPINA1 mRNA expression in A549 human lung epithelial cells.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 622, doi. 10.1002/ddr.21891
- By:
- Publication type:
- Article
Augmented antiviral T cell immunity by oral administration of IMM‐124E in preclinical models and a phase I/IIa clinical trial: A method for the prevention and treatment of COVID‐19.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 615, doi. 10.1002/ddr.21890
- By:
- Publication type:
- Article
9‐Ethynyl noscapine induces G2/M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 605, doi. 10.1002/ddr.21888
- By:
- Publication type:
- Article
Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin‐4(3H)‐one derivatives as potential aldose reductase inhibitors.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 586, doi. 10.1002/ddr.21887
- By:
- Publication type:
- Article
Innovative antimicrobial substances based on uracil S‐derivatives.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 578, doi. 10.1002/ddr.21886
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Drug Development Research, 2022, v. 83, n. 3, p. 565, doi. 10.1002/ddr.21825
- Publication type:
- Article